[go: up one dir, main page]

Shin et al., 2013 - Google Patents

The immature dentate gyrus represents a shared phenotype of mouse models of epilepsy and psychiatric disease

Shin et al., 2013

View PDF
Document ID
13596535937305877462
Author
Shin R
Kobayashi K
Hagihara H
Kogan J
Miyake S
Tajinda K
Walton N
Gross A
Heusner C
Chen Q
Tamura K
Miyakawa T
Matsumoto M
Publication year
Publication venue
Bipolar Disorders

External Links

Snippet

Objectives There is accumulating evidence to suggest psychiatric disorders, such as bipolar disorder and schizophrenia, share common etiologies, pathophysiologies, genetics, and drug responses with many of the epilepsies. Here, we explored overlaps in …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Shin et al. The immature dentate gyrus represents a shared phenotype of mouse models of epilepsy and psychiatric disease
Pandya et al. Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective
Takahashi et al. Glutamate input in the dorsal raphe nucleus as a determinant of escalated aggression in male mice
Jeffries et al. ERK1/2 activation in preexisting oligodendrocytes of adult mice drives new myelin synthesis and enhanced CNS function
Zoladz et al. Differential expression of molecular markers of synaptic plasticity in the hippocampus, prefrontal cortex, and amygdala in response to spatial learning, predator exposure, and stress‐induced amnesia
Marowsky et al. A specialized subclass of interneurons mediates dopaminergic facilitation of amygdala function
Li et al. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter
Martin et al. α5GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory
Qiu et al. Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice
Lam et al. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α‐synuclein
Gantz et al. Spontaneous inhibitory synaptic currents mediated by a G protein-coupled receptor
Sciamanna et al. Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia
Wyatt et al. Sociocommunicative and sensorimotor impairments in male P2X4-deficient mice
Bouzioukh et al. NMDA receptor and nitric oxide synthase activation regulate polysialylated neural cell adhesion molecule expression in adult brainstem synapses
Schulz et al. Enhanced dendritic inhibition and impaired NMDAR activation in a mouse model of down syndrome
Severino et al. Mu-opioid receptors in nociceptive afferents produce a sustained suppression of hyperalgesia in chronic pain
Aman et al. Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's disease
Kervern et al. Aberrant NMDA‐dependent LTD after perinatal ethanol exposure in young adult rat hippocampus
Truchet et al. Kv4 potassium channels modulate hippocampal EPSP-spike potentiation and spatial memory in rats
Mackay et al. NPY2 receptors reduce tonic action potential-independent GABAB currents in the basolateral amygdala
Lepousez et al. Somatostatin contributes to in vivo gamma oscillation modulation and odor discrimination in the olfactory bulb
Du et al. The contributions of mu-opioid receptors on glutamatergic and GABAergic neurons to analgesia induced by various stress intensities
Bosse et al. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8‐deficient mice
MS Lima et al. Paradoxical sleep deprivation modulates tyrosine hydroxylase expression in the nigrostriatal pathway and attenuates motor deficits induced by dopaminergic depletion
Torturo et al. Isoflurane inhibits dopaminergic synaptic vesicle exocytosis coupled to CaV2. 1 and CaV2. 2 in rat midbrain neurons